# Ameris Bancorp: financial statements, quarterly

ABCB · NYSE · CIK 351569 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abcb.md) · [Financials](/companies/abcb/financials.md) · [Filings](/companies/abcb/filings.md) · [Insiders](/companies/abcb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/abcb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [123](/filings/0000351569-23-000028.md) | [126 d](/filings/0000351569-24-000006.md) | [128](/filings/0000351569-24-000012.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [24.9](/filings/0000351569-24-000039.md) | [24.5 d](/filings/0000351569-26-000050.md) | [23.1](/filings/0000351569-25-000011.md) | [35.7](/filings/0000351569-25-000022.md) | [26.7](/filings/0000351569-25-000037.md) | [31.6 d](/filings/0000351569-26-000050.md) | [25.0](/filings/0000351569-26-000086.md) | [32.9](/filings/0000351569-26-000143.md) | [31.0](/filings/0000351569-25-000037.md) | [32.7 d](/filings/0000351569-26-000050.md) | [30.2](/filings/0000351569-26-000086.md) | [14.6](/filings/0000351569-26-000143.md) |
| Net income | $m | [80.1](/filings/0000351569-24-000039.md) | [65.9 d](/filings/0000351569-26-000050.md) | [74.3](/filings/0000351569-25-000011.md) | [90.8](/filings/0000351569-25-000022.md) | [99.2](/filings/0000351569-25-000037.md) | [94.4 d](/filings/0000351569-26-000050.md) | [87.9](/filings/0000351569-26-000086.md) | [110](/filings/0000351569-26-000143.md) | [106](/filings/0000351569-25-000037.md) | [108 d](/filings/0000351569-26-000050.md) | [110](/filings/0000351569-26-000086.md) | [51.4](/filings/0000351569-26-000143.md) |
| Diluted EPS | $ per share | [1.16](/filings/0000351569-24-000039.md) | not reported | [1.08](/filings/0000351569-25-000011.md) | [1.32](/filings/0000351569-25-000022.md) | [1.44](/filings/0000351569-25-000037.md) | not reported | [1.27](/filings/0000351569-26-000086.md) | [1.60](/filings/0000351569-26-000143.md) | [1.54](/filings/0000351569-25-000037.md) | not reported | [1.63](/filings/0000351569-26-000086.md) | [0.77](/filings/0000351569-26-000143.md) |
| Basic EPS | $ per share | [1.16](/filings/0000351569-24-000039.md) | not reported | [1.08](/filings/0000351569-25-000011.md) | [1.32](/filings/0000351569-25-000022.md) | [1.44](/filings/0000351569-25-000037.md) | not reported | [1.28](/filings/0000351569-26-000086.md) | [1.60](/filings/0000351569-26-000143.md) | [1.55](/filings/0000351569-25-000037.md) | not reported | [1.64](/filings/0000351569-26-000086.md) | [0.77](/filings/0000351569-26-000143.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [25.7](/filings/0000351569-24-000039.md) | [25.2](/filings/0000351569-26-000050.md) | [25.7](/filings/0000351569-25-000011.md) | [26.5](/filings/0000351569-25-000022.md) | [26.4](/filings/0000351569-25-000037.md) | [26.3](/filings/0000351569-26-000050.md) | [26.5](/filings/0000351569-26-000086.md) | [26.7](/filings/0000351569-26-000143.md) | [27.1](/filings/0000351569-25-000037.md) | [27.5](/filings/0000351569-26-000143.md) | [28.1](/filings/0000351569-26-000086.md) | [28.5](/filings/0000351569-26-000143.md) |
| Total liabilities | $bn | [22.4](/filings/0000351569-23-000028.md) | [21.8](/filings/0000351569-25-000006.md) | [22.2](/filings/0000351569-24-000012.md) | [23.0](/filings/0000351569-24-000029.md) | [22.7](/filings/0000351569-24-000039.md) | [22.5](/filings/0000351569-26-000050.md) | [22.7](/filings/0000351569-25-000011.md) | [22.8](/filings/0000351569-25-000022.md) | [23.1](/filings/0000351569-25-000037.md) | [23.4](/filings/0000351569-26-000143.md) | [24.0](/filings/0000351569-26-000086.md) | [24.4](/filings/0000351569-26-000143.md) |
| Shareholders' equity | $bn | [3.3](/filings/0000351569-24-000039.md) | [3.4](/filings/0000351569-26-000050.md) | [3.5](/filings/0000351569-25-000022.md) | [3.6](/filings/0000351569-25-000037.md) | [3.7](/filings/0000351569-25-000037.md) | [3.8](/filings/0000351569-26-000143.md) | [3.8](/filings/0000351569-26-000143.md) | [3.9](/filings/0000351569-26-000143.md) | [4.0](/filings/0000351569-25-000037.md) | [4.1](/filings/0000351569-26-000143.md) | [4.1](/filings/0000351569-26-000143.md) | [4.1](/filings/0000351569-26-000143.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [132 d](/filings/0000351569-24-000039.md) | [213 d](/filings/0000351569-26-000050.md) | [18.6](/filings/0000351569-25-000011.md) | [(97.1) d](/filings/0000351569-25-000022.md) | [102 d](/filings/0000351569-25-000037.md) | [131 d](/filings/0000351569-26-000050.md) | [117](/filings/0000351569-26-000086.md) | [61.4 d](/filings/0000351569-26-000143.md) | [105 d](/filings/0000351569-25-000037.md) | [107 d](/filings/0000351569-26-000050.md) | [257](/filings/0000351569-26-000086.md) | [79.4 d](/filings/0000351569-26-000143.md) |
| Capital expenditure | $m | [3.8 d](/filings/0000351569-24-000039.md) | [5.9 d](/filings/0000351569-26-000050.md) | [3.4](/filings/0000351569-25-000011.md) | [3.3 d](/filings/0000351569-25-000022.md) | [2.4 d](/filings/0000351569-25-000037.md) | [4.4 d](/filings/0000351569-26-000050.md) | [2.7](/filings/0000351569-26-000086.md) | [7.7 d](/filings/0000351569-26-000143.md) | [4.4 d](/filings/0000351569-25-000037.md) | [5.8 d](/filings/0000351569-26-000050.md) | [7.7](/filings/0000351569-26-000086.md) | [8.6 d](/filings/0000351569-26-000143.md) |
| Dividends paid | $m | [10.3 d](/filings/0000351569-24-000039.md) | [10.3 d](/filings/0000351569-26-000050.md) | [10.5](/filings/0000351569-25-000011.md) | [10.3 d](/filings/0000351569-25-000022.md) | [10.3 d](/filings/0000351569-25-000037.md) | [10.3 d](/filings/0000351569-26-000050.md) | [14.1](/filings/0000351569-26-000086.md) | [13.7 d](/filings/0000351569-26-000143.md) | [13.7 d](/filings/0000351569-25-000037.md) | [13.7 d](/filings/0000351569-26-000050.md) | [14.0](/filings/0000351569-26-000086.md) | [13.4 d](/filings/0000351569-26-000143.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [69.3](/filings/0000351569-23-000028.md) | [69.3](/filings/0000351569-24-000012.md) | [69.0](/filings/0000351569-24-000029.md) | [69.0](/filings/0000351569-24-000039.md) | [69.0](/filings/0000351569-25-000011.md) | [69.0](/filings/0000351569-25-000022.md) | [69.1](/filings/0000351569-25-000037.md) | [69.0](/filings/0000351569-26-000086.md) | [68.8](/filings/0000351569-26-000143.md) | [68.7](/filings/0000351569-25-000037.md) | [67.8](/filings/0000351569-26-000086.md) | [67.1](/filings/0000351569-26-000143.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 67,107,239 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0000351569-26-000143.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.